• Pure Extracts working on innovative, larger capacity cartridge for vape products, destined for Canadian retail market
• Cartridges to be produced by global manufacturer, will be filled with selection of Pure Extracts’ 30+ proprietary cannabis FSO formulations
• Move towards larger cartridges follows careful assessment of underlying consumer trends by the Company, finding demand for higher capacity vape cartridges to be particularly strong within provincial markets

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on the cannabis, hemp, functional mushrooms and rapidly emerging psychedelic sector, announced that its wholly owned subsidiary, Pure Extracts Manufacturing Corp., has developed and is currently engaging in the production of innovative 1 gram, full spectrum oil (“FSO”), vape cartridges for the Canadian retail market (https://ibn.fm/4tRa6). 

The CBD vape market has been a beneficiary of strong customer demand as of late, with Data Bridge Market Research forecasting that the sector could be worth as much as $28.05 billion by 2027 (https://ibn.fm/70TBH). CBD oil usage has increased across a range of medical applications, such as the treatment of anxiety and depression, stress relief, diabetes prevention, pain mitigation, the alleviation of cancer symptoms, and even acne reduction. These are all factors singled out by Data Bridge as key drivers underpinning demand growth within the segment.

The production of higher capacity vape cartridges for the Canadian retail market has been undertaken by Pure Extracts following close observation of underlying consumer trends. In addition to a change in consumer preferences, Pure Extracts has found demand for larger cartridges to be particularly strong within provincial markets, with the product offering exceptional value to customers while simultaneously generating higher margins for the Company. Pure Extracts’ cartridges will be filled with a selection of some of the Company’s 30+ proprietary cannabis FSO formulations, including Super Lemon Haze, Grand Daddy Purple and GSK. 

“We are proud to be a leading innovator in the cannabis vape sector,” stated Pure Extracts CEO Ben Nikolaevsky. “The combination of a larger form factor with our exceptional cannabis extracts will definitely build on the loyal following Pure Pulls already has in-place.”

The production of the new 510 vape cartridges will be produced by a global manufacturer and adhere to the highest North American test standards. The cartridges have been specifically chosen for the quality of their component parts, their fit and finish, as well as their performance characteristics when paired with Pure Extracts’ oil concentrates. 

For more information, visit the company’s website at www.PureExtractsCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to PULL are available in the company’s newsroom at https://ibn.fm/PULL

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.